Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Human Vaccines & Immunotherapeutics
|
December 9, 2014
Immunocompetent mouse models to evaluate intrahepatic T cell responses to HCV vaccines
Wenbo Yu, Branka Grubor-Bauk, Ranajoy Mullick, et al.
Current Microbiology
|
August 16, 2022
A Single Mutation in the Cryptic AUG (cAUG) Affects In Vitro Translation and Replication Efficiencies and In Vivo Virulence of Coxsackievirus B3 (CVB3)
Ahlem Ben Youssef, Jawhar Gharbi, Biju George, et al.
The Journal of Biological Chemistry
|
August 29, 2019
The mammalian host protein DAP5 facilitates the initial round of translation of Coxsackievirus B3 RNA
Pratik Dave, Biju George, Harsha Raheja, et al.
Virus Research
|
September 26, 2018
Interaction of miR-125b-5p with Human antigen R mRNA: Mechanism of controlling HCV replication
Shivaprasad Shwetha, Geetika Sharma, Harsha Raheja, et al.
Scientific Reports
|
April 4, 2013
Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis
Shivaprasad Shwetha, K Gouthamchandra, Madhavi Chandra, et al.
Antiviral Research
|
January 8, 2013
A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus
Asit Kumar Manna, Anuj Kumar, Upasana Ray, et al.
The Journal of General Virology
|
June 19, 2008
Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication
Swagata Roy, Nidhi Gupta, Nithya Subramanian, et al.
Biochemistry
|
August 30, 2024
Helical Domain Changes between hGBP3 and hGBP3ΔC Result in Distinct Oligomers and Anti-HCV Activity
Sowmiya Gupta, Aunji Pradhan, Divya Rashmi, et al.
Journal of Virology
|
October 3, 2008
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA
Tanmoy Mondal, Upasana Ray, Asit Kumar Manna, et al.
ACS Applied Bio Materials
|
January 12, 2022
Galactose Functionalized Mesoporous Silica Nanoparticles As Delivery Vehicle in the Treatment of Hepatitis C Infection
Mousumi Beto Mukherjee, Ranajoy Mullick, B Uma Reddy, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Human Vaccines & Immunotherapeutics
|
December 9, 2014
Immunocompetent mouse models to evaluate intrahepatic T cell responses to HCV vaccines
Wenbo Yu, Branka Grubor-Bauk, Ranajoy Mullick, et al.
Current Microbiology
|
August 16, 2022
A Single Mutation in the Cryptic AUG (cAUG) Affects In Vitro Translation and Replication Efficiencies and In Vivo Virulence of Coxsackievirus B3 (CVB3)
Ahlem Ben Youssef, Jawhar Gharbi, Biju George, et al.
The Journal of Biological Chemistry
|
August 29, 2019
The mammalian host protein DAP5 facilitates the initial round of translation of Coxsackievirus B3 RNA
Pratik Dave, Biju George, Harsha Raheja, et al.
Virus Research
|
September 26, 2018
Interaction of miR-125b-5p with Human antigen R mRNA: Mechanism of controlling HCV replication
Shivaprasad Shwetha, Geetika Sharma, Harsha Raheja, et al.
Scientific Reports
|
April 4, 2013
Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis
Shivaprasad Shwetha, K Gouthamchandra, Madhavi Chandra, et al.
Antiviral Research
|
January 8, 2013
A cyclic peptide mimic of an RNA recognition motif of human La protein is a potent inhibitor of hepatitis C virus
Asit Kumar Manna, Anuj Kumar, Upasana Ray, et al.
The Journal of General Virology
|
June 19, 2008
Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication
Swagata Roy, Nidhi Gupta, Nithya Subramanian, et al.
Biochemistry
|
August 30, 2024
Helical Domain Changes between hGBP3 and hGBP3ΔC Result in Distinct Oligomers and Anti-HCV Activity
Sowmiya Gupta, Aunji Pradhan, Divya Rashmi, et al.
Journal of Virology
|
October 3, 2008
Structural determinant of human La protein critical for internal initiation of translation of hepatitis C virus RNA
Tanmoy Mondal, Upasana Ray, Asit Kumar Manna, et al.
ACS Applied Bio Materials
|
January 12, 2022
Galactose Functionalized Mesoporous Silica Nanoparticles As Delivery Vehicle in the Treatment of Hepatitis C Infection
Mousumi Beto Mukherjee, Ranajoy Mullick, B Uma Reddy, et al.
Page
of 11